Introduction

Na+/K+-ATPase is responsible for the active transport of sodium and potassium ions, and it is essential for maintaining membrane potentials, cell volume, and the active transport of other solutes in animal cells1. In addition, this enzyme is a P-type ATPase, also known as a sodium pump, which commonly consumes 20%–30% of the adenosine triphosphate (ATP) energy generated in animal cells at rest to actively transport three Na+ out of the cell and two K+ into the cell2. The Na+/K+-ATPase structure comprises three subunits, termed the α, β and γ subunits, that execute distinct biological functions3,4,5. The sites for ATP binding, phosphorylation and ion occlusion are located in the α subunit. This subunit also contains an inhibitor-binding cavity that serves as the primary target for many pharmacological agents, such as cardiac glycosides6,7,8.

The therapeutic effect of cardiac glycosides in the treatment of congestive heart failure derives from their reversible inhibition of the Na+/K+-ATPase located in the cell membrane of the human myocardium9,10. This inhibition leads to the accumulation of sodium in cardiac cells, the promotion of the sodium-calcium exchange system in the cell membrane, and ultimately, a higher level of intracellular and myocardial calcium11. The elevated intracellular calcium concentration results in an increased inotropism, accentuating the force of myocardial contractions by increasing the velocity and extent of sarcomere shortening. In other words, there is increased stroke work for a given filling volume of pressure12. Although inhibition of the Na+/K+-ATPase produces beneficial effects in patients with congestive heart failure, cardiac glycosides have severe side effects and a narrow therapeutic index, limiting their clinical applications13.

Recently, a number of steroid-like compounds from diverse Chinese medicinal products used for promoting blood circulation were demonstrated to be effective inhibitors of Na+/K+-ATPase; thus, these compounds could exert therapeutic cardiac effects via the same molecular mechanisms as cardiac glycosides14,15,16,17,18. Exceptionally, no appreciable steroid-like compound content was found in danshen (Salvia miltiorrhiza), a well-known Chinese herb traditionally used for promoting blood circulation19. Instead, magnesium lithospermate B (Mg-LSB), the major soluble ingredient in danshen, was demonstrated to be a strong inhibitor of Na+/K+-ATPase and is regarded as the active ingredient responsible for the therapeutic cardiac effect of this herb20. Mg-LSB may have the potential to be a substitute for cardiac glycosides in the treatment of congestive heart failure because it is a non-toxic antioxidant and appears to have no adverse effects; however, clinical trials assessing the efficacy of this compound are lacking21.

Mg-LSB possesses a relatively rigid structure as a result of the formation of salt bridges between Mg2+ and the four oxygen atoms of the carboxyl groups that originated from the four caffeic acid fragments22. The rigid structure around the salt bridges formed between Mg2+ and the carboxyl groups partially mimics the core steroid structure of cardiac glycosides. To develop more effective drugs for the treatment of congestive heart failure, we sought to determine whether the magnesium ion of Mg-LSB could be replaced with other metal ions to form complexes with a higher potency for inhibiting Na+/K+-ATPase activity. In this study, abundant metal ions and trace transition metal ions found in the human body were used to form soluble complexes with LSB. The potency of these complexes for inhibiting Na+/K+-ATPase activity and their cytotoxicity was evaluated. As exemplified by the formation of a Co-LSB complex, the transition metal binding site in LSB and the binding modes with different ratios of Co2+ to LSB were also examined.

Materials and methods

Chemicals and reagents

Purified LSB was obtained from KO DA Pharmaceutical Company (Taiwan, China). Mg(OH)2 was purchased from Showa Chemical Co (Japan). NaOH, KOH, CrCl3, MnCl2, CoCl2, and NiCl2 were purchased from Sigma-Aldrich (St Louis, MO, USA). The phosphate assay kit was purchased from Amresco (Solon, OH, USA). Penicillin, streptomycin, Dulbeco's modified Eagle's medium (DMEM), Roswell Park Memorial Institute (RPMI) medium 1640, and Dulbecco's phosphate buffered saline (DPBS) were purchased from GIBCO (Grand, Island, NY, USA). Fluo-4-AM was purchased from Invitrogen (Burlington, Ontario, Canada). Fetal bovine serum (FBS) was purchased from Hyclone (Logan, UT, USA). Water soluble tetrazolium (WST-1) was purchased from Biovision (Mountain View, CA, USA).

Preparation of metal-LSB complexes

Na-LSB, K-LSB, Mg-LSB, and Zn-LSB complexes were prepared in 1 mL of H2O by mixing LSB (to a final concentration of 10 mmol/L) with NaOH (20 mmol/L), KOH (20 mmol/L), Mg(OH)2 (10 mmol/L), or Zn(OH)2 (10 mmol/L), respectively. To prepare Cr-LSB, Mn-LSB, Co-LSB, and Ni-LSB complexes, LSB (10 mmol/L) was first precipitated with NaOH (20 mmol/L) in 1 mL of ethanol, and the precipitate was then dissolved by adding CrCl3, MnCl2, CoCl2, or NiCl2 (10 mmol/L) to form a metal-LSB complex.

Inhibition of Na+/K+-ATPase by metal-LSB complexes

The activity of Na+/K+-ATPase was determined by measuring the amount of inorganic phosphate (Pi) liberated from ATP20. A commercial Na+/K+-ATPase from porcine cerebral cortex (Sigma, 0.3 units/mg) was added to 500 μL of the reaction solution containing 1 mmol/L ATP, 3 mmol/L MgCl2, 48 mmol/L NaCl, 12 mmol/L KCl, and 24 mmol/L Tris-HCl (pH 7.8). The enzymatic reaction was terminated by adding 250 μL of 30% (w/v) trichloroacetic acid after the incubation period. After centrifugation at 10 000×g for 10 min at 4 °C, the supernatant was diluted 12.5-fold with deionized water. Next, 50 μL of color development reagent provided by the phosphate assay kit was added to the solution. After 30 min of incubation at room temperature, the color intensity was measured at 620 nm on a SpectraMax M2 reader (Molecular Devices, USA). Sodium pump activity was expressed as μmol Pi liberated from ATP by 1 mg of Na+/K+-ATPase in 1 h. The relative activity was calculated as the level of sodium pump activity in the presence of LSB, metal-LSB complexes, and metal ions when normalized to a control of deionized water only (100%).

Cell cultures

The human adrenergic neuroblastoma cell line SH-SY5Y23 was kindly provided by Dr Tin-yun HO of the Graduate Institute of Chinese Medical Science at China Medical University in Taiwan, China. SH-SY5Y cells grown in RPMI-1640 culture medium supplemented with 10% FBS and 1% L-glutamine were maintained at 37 °C in a humidified atmosphere of 95% air/5% CO2. Cell passages were performed every other day by trypsinization. For fluorescence imaging, cells were plated in 3-cm cell culture dishes and grown to 80% confluency (approximately 48 h). H9c2 cells (rat cardiomyoblast cell line) were obtained from the Bioresource Collection and Research Center (Hsinchu, Taiwan, China). H9c2 cells grown in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and 1.5 g of sodium bicarbonate were maintained at 37 °C in a humidified atmosphere of 95% air/5% CO2. Cell passages were performed every other day by trypsinization. For WST-1 staining, cells were plated in a 96-well culture plate at a density of 1×104 cells.

Intracellular Ca2+ imaging

Fluctuations in the intracellular Ca2+ levels of SH-SY5Y cells were tracked and visualized with the preloaded fluorescent Ca2+-sensitive dye Fluo4-AM21,24. Cell-permeable Fluo4-AM was dissolved in DMSO at a concentration of 4 mmol/L. The dye was then further diluted to 4 μmol/L in RPMI-1640 culture medium. The cells were washed once with DPBS, and then RPMI-1640 culture medium supplemented with 4 μmol/L Fluo4-AM was added to the cells for 30 min in a humidified 5% CO2 incubator at 37 °C. After washing in DPBS and RPMI-1640 culture medium, 25 μmol/L of Mg-LSB, Cr-LSB, Mn-LSB, Co-LSB, Ni-LSB, or ouabain was added to the cells. Ca2+ fluorescence imaging was monitored at multiple intervals over 20 min. Time-lapse images of live cells loaded with Fluo4-AM were collected using IX71 inverted microscopy (Olympus, Tokyo, Japan). Fluctuations in fluorescence intensity of SH-SY5Y cells treated with metal-LSBs and ouabain were analyzed frame by frame with a Time Series Analyzer25,26. This plugin was used to analyze time-lapse image stacks. Cells were selected in a region of interest (ROI), and the fluorescence intensity of each time point was measured.

Cell viability assay

H9c2 cells were treated with ouabain, LSB and metal-LSB complexes at a concentration ranging from 10 nmol/L to 100 μmol/L for 24 h. Next, these cells were subjected to cell viability assay using WST-1. The absorbance was measured at 440 nm on a SpectraMax M2 reader. Control cells underwent the same conditions without the addition of any drugs. Cell viability is expressed as a percentage of the absorbance of treated cells over the absorbance of control cells.

NMR spectroscopic studies

LSB was dissolved in 1 mL of ethanol to a final concentration of 15 mmol/L and then precipitated by titrating with NaOH (30 mmol/L). The precipitated LSB was re-dissolved by adding CoCl2 (15 mmol/L) to the ethanol solution. Ethanol was removed in vacuum, and the dried sample was dissolved in D2O. The 13C NMR spectra of LSB and Co-LSB dissolved in D2O were obtained using a Varian Unity Inova-600 NMR spectrometer (Blue Lion Biotech, WA, USA).

Visible spectroscopic studies

LSB was dissolved in 1 mL of methanol to a final concentration of 15 mmol/L. Next, NaOH (30 mmol/L) was added. CoCl2 was dissolved in methanol to a final concentration of 400 mmol/L. A titration experiment was performed by sequential addition of the CoCl2 solution to the LSB preparation in a quartz cuvette. The spectroscopic changes in the solution were monitored. Visible spectra were obtained using a Jasco V500 spectrometer (Jasco Corporation, Tokyo, Japan).

Statistical analysis

Data are expressed as the mean±standard error of mean (SEM) of 4 replicates. An analysis of variance (One-way ANOVA) was performed using SPSS 12.0 for Windows. Differences were considered statistically significant at P<0.05.

Results

Potency of metal-LSB complexes for inhibiting Na+/K+-ATPase

Three relatively abundant metal ions (Na+, K+, and Mg2+) found in the human body and five transition metal ions (Cr3+, Mn2+, Co2+, Ni2+, and Zn2+) regarded as trace essential elements in human biological functions were used to form soluble complexes with LSB. The potency of these eight metal-LSB complexes (50 μmol/L) for inhibiting Na+/K+-ATPase activity was determined and compared with that of LSB (Figure 1A). The results showed that the inhibitory potency of LSB was significantly enhanced by forming a complex with any of the five transition metal ions but not with Na+, K+, or Mg2+. To determine whether the enhancement of inhibitory potency for Na+/K+-ATPase was due to the presence of metal ions, eight metal ions of equivalent concentrations were subjected to the same assay. The results showed only Zn2+ affected Na+/K+-ATPase activity (Figure 1B). Therefore, Zn-LSB was excluded in the subsequent studies of metal-LSB complexes. Quantitatively, the IC50 value of LSB (101 μmol/L) and Mg-LSB (128 μmol/L) was approximately 5 times higher than that of Cr-LSB (23 μmol/L), Mn-LSB (17 μmol/L), Co-LSB (26 μmol/L), or Ni-LSB (25 μmol/L) (Figure 2).

Figure 1
figure 1

(A) The inhibition of porcine Na+/K+-ATPase by 50 μmol/L of metal-LSB complexes. (B) The inhibition of porcine Na+/K+-ATPase by 50 μmol/L of the metal ions used in the metal-LSB complexes. The inhibitory potency of the complexes and metal ions was determined by the reduction of Pi liberation from ATP by a constant amount of commercial porcine Na+/K+-ATPase. The data represent the mean±SEM of five replicates. cP<0.01 vs LSB only or control group (Con; deionized water only).

PowerPoint slide

Figure 2
figure 2

The potency of LSB and metal-LSB complexes for inhibiting porcine Na+/K+-ATPase. The inhibitory potency of various concentrations of LSB, Mg-LSB and four transition metal-LSB complexes was determined by the reduction of Pi liberation from ATP by a constant amount of commercial porcine Na+/K+-ATPase.

PowerPoint slide

Effects of metal-LSB complexes on intracellular Ca2+ levels in SH-SY5Y cells

To examine the effects of the four transition metal-LSB complexes (Cr3+, Mn2+, Co2+, and Ni2+) on intracellular Ca2+ levels, SH-SY5Y cells were preloaded with Fluo4-AM and then incubated with 25 μmol/L of a metal-LSB complex or ouabain. Cells were monitored for intracellular fluorescence fluctuations at multiple intervals over 20 min. Compared with cells treated with buffer alone (control), SH-SY5Y cells treated with any of the metal-LSB complexes displayed a significantly elevated fluorescence intensity (Figure 3). These results indicate that the metal-LSB complexes and ouabain increased the intracellular Ca2+ levels of SH-SY5Y cells.

Figure 3
figure 3

Fluctuations in intracellular Ca2+ levels of SH-SY5Y cells treated with metal-LSB complexes. SH-SY5Y cells were loaded with Fluo4-AM prior to incubation with 25 μmol/L of a metal-LSB complex or ouabain. The intensity of fluorescence was recorded at multiple time intervals over 20 min (A). Each point is representative of time-lapse images in three independent experiments. Serial images of cells treated with metal-LSB complexes and ouabain for 1, 5, 9, and 20 min were captured to display the fluctuation of intracellular Ca2+ levels (B). The scale bar represents 20 μm.

PowerPoint slide

Cytotoxicity of metal-LSB complexes on H9c2 cells

To evaluate the cytotoxicity of the four transition metal-LSB complexes on cardiomocytes, H9c2 cells were treated with various concentrations (0.01–100 μmol/L) of these four complexes for 24 h. Next, the cell viability was examined and compared with that of cells treated with the same concentrations of LSB or Mg-LSB (Figure 4). No apparent cytotoxicity was observed in H9c2 cells treated with any of the four transition metal-LSB complexes, except for cells treated with 100 μmol/L of Mn-LSB. Based on these data, H9c2 cells were viable for at least one day when treated with metal-LSB complexes of concentrations lower than 10 μmol/L. Interestingly, the viability of H9c2 cells treated with 100 μmol/L of Co-LSB was substantially higher compared with other treatments. It is possible that Co-LSB increased the growth or decreased the necrosis of H9c2 cells27.

Figure 4
figure 4

The effects of LSB and metal-LSB complexes on the viability of H9c2 cells. H9c2 cells were treated with various concentrations of LSB, Mg-LSB or four transition metal-LSB complexes for 24 h. Cell viability was measured using a WST-1 assay. The data are represented as the mean±SEM (n=4; 4 wells in the same experiment).

PowerPoint slide

Identification of the Co2+-binding site in LSB by NMR spectroscopy

Regarding the paramagnetic properties of the four transition metal-LSB complexes examined, Co-LSB possessed a clear signal pattern in 13C NMR spectroscopy; therefore, we used this complex to study the interaction between a transition metal and LSB. To identify the Co2+-binding site in LSB, the 13C NMR spectra of LSB and Co-LSB were compared (Figure 5A). In comparison with the 13C NMR spectrum of LSB, the signals for C8″, C8′″, C9″, and C9′″ were completely eliminated. The signal for C9', but not C9, was significantly quenched in the 13C NMR spectrum of Co-LSB. These data suggest that two carboxylate groups and one carbonyl group of LSB are responsible for coordinating to Co2+. The negatively charged carboxylate groups of LSB seem to play a key role in the chelation of the positively charged transition metal ions. Based on our NMR spectral analysis, a 2D structure of Co-LSB is depicted in Figure 5B.

Figure 5
figure 5

(A) The 13C NMR spectra of LSB and Co-LSB. The NMR signals of C-8″, C-8′″, C-9″, and C9′″ in the LSB spectrum indicated by arrows were quenched in the Co-LSB spectrum. The NMR signal of C-9′ in the LSB spectrum was substantially reduced in the Co-LSB spectrum when compared with that of C-9. (B) The proposed 2D structure of Co-LSB. The solid and dashed lines between Co2+ and oxygen atoms of LSB represent strong and weak interactions, respectively.

PowerPoint slide

Detection of binding modes of LSB and Co2+ by visible spectroscopy

LSB was incorporated with different concentrations of Co2+. Next, the d-d orbital electron transition was monitored by visible spectroscopic changes in different binding modes of LSB and Co2+. The absorbance of LSB (15 mmol/L) at 400–800 nm was rapidly elevated when the [Co2+] increased from 0 to 7.5 mmol/L; however, further elevation of the absorbance was slowed as the [Co2+] increased from 7.5 to 15 mmol/L (Figure 6A). No apparent elevation of absorbance was observed when the [Co2+] was increased from 15 to 30 mmol/L, except for the absorbance between 500 and 550 nm. This result was observed presumably because of the absorbance of non-coordinated Co2+, which has a maximal absorbance at 529 nm in methanol. The titration curve of the absorbance at 420 nm suggested that complexes were formed with a Co2+:LSB molar ratio of 1:2 and 1:1 when [Co2+] was lower than 7.5 mmol/L and higher than 15 mmol/L, respectively (Figure 6B). The absorbance at 420 nm was minimally elevated and plateaued when the [Co2+] was higher than [LSB] (15 mmol/L). Obviously, excess Co2+ could not bind to LSB after forming the Co-LSB complex at a 1:1 molar ratio. The presence of excess Co2+ existing in its free form is in agreement with the unique elevation of absorbance between 500 and 550 nm when the [Co2+] was increased from 15 to 30 mmol/L, as shown in Figure 6A.

Figure 6
figure 6

(A) The visible spectra of LSB in complex with various concentrations of Co2+. (B) The absorbance intensity of LSB titrated against Co2+ at 420 nm. The change in LSB intensity titrated against Co2+ could be separated into three parts, including a fast increment from 0 to 7.5 mmol/L, a slow increment from 7.5 to 15 mmol/L, and no obvious change from 15 to 30 mmol/L.

PowerPoint slide

Discussion

In light of the narrow safety margin and severe side effects of cardiac glycosides in the treatment of congestive heart failure, researchers have extensively searched for potential substitutes isolated from natural sources or novel drugs rationally developed through chemical synthesis and modification15,28,29,30,31,32. Side effects are unlikely to be eliminated for candidate drugs that possess the same steroid backbone, or a similar one, as that of cardiac glycosides. In our recent screening of many Chinese medicines used for the promotion of blood circulation, numerous analogues of steroid-like compounds were identified as the active ingredient responsible for the therapeutic effect; furthermore, these compounds utilized the same molecular mechanism triggered by cardiac glycosides19. Surprisingly, Mg-LSB, a non-steroid antioxidant without apparent adverse effects, was identified as the active ingredient in danshen, and it was proposed to be a potential substitute for cardiac glycosides20. In our current study, we successfully replaced the Mg2+ of Mg-LSB with transition metal ions. The resulting transition metal-LSB complexes displayed an inhibitory potency approximately 5 times higher than LSB or Mg-LSB. No apparent cytotoxicity from these transition metal-LSB complexes (except for 100 μmol/L Mn-LSB) was observed in cardiomocytes. Our data suggest that some of these transition metal-LSB complexes may be superior substitutes for cardiac glycosides in the treatment of congestive heart failure, provided that they undergo necessary clinical trials.

The drastic difference in inhibitory potency for Na+/K+-ATPase between Mg-LSB and Co-LSB (Figure 3) indicates that Mg2+ and Co2+ might interact with LSB differently. Similar to our observations (data not shown), it has been previously shown that the 13C NMR spectra of LSB and Mg-LSB are essentially identical33; more specifically, the signals for C8″, C8′″, C9″ and C9′″ of Mg-LSB did not disappear, and the signal for C9' of Mg-LSB was not significantly quenched compared with the 13C NMR spectrum of Co-LSB. Presumably, Co2+, but not Mg2+, interacts strongly with the two carboxylate groups at C9″ and C9′″ of LSB and weakly with the carbonyl group at C9' of LSB. These interactions likely lead to a more rigid structure of Co-LSB that might be a better fit than Mg-LSB or LSB within the binding pocket of Na+/K+-ATPase. The detailed structural differences between Mg-LSB and Co-LSB as well as the variance of their molecular interaction with the residues around the binding pocket of Na+/K+-ATPase needs to be investigated.

In terms of chemical characteristics, many active ingredients in Chinese herbs, particularly phenolic compounds clustered with oxygen-containing functional groups, tend to chelate metal ions. Chelation of metal ions might affect the bioactivities of phenolic compounds, such as baicalein and baicalin. These two major bioactive compounds in the Chinese herb Scutellaria baicalensis were found to form complexes with Fe2+and Fe3+ that possessed distinctive anti-Fenton properties34. Similar iron-binding properties of quercetin, the major phenolic compound in cranberries, were also observed and were proposed to be effective at modulating cellular iron homeostasis under physiological conditions35. Moreover, the biological activities of catechins, the active components in green tea, have been reported to be influenced by metal ions, especially transition metal ions. For example, Mn2+ was found to coordinate to the B- and D-rings of epigallocatechin gallate (the most abundant catechin in green tea), while Al3+ tended to coordinate to only the D-ring36,37. As shown by our findings on enhancing the potency of transition metal-LSB complexes for inhibiting Na+/K+-ATPase activity, we suggest that the chelation of active ingredients from Chinese herbs, by using metal ions, may be an applicable approach to improving the therapeutic effects of these herbs.

Author contribution

Jason TC TZEN and Hsin-An CHEN designed the study; Nan-Hei LIN and Tse-yu CHUNG performed the experiments; Feng-yin LI contributed new analytical tools and reagents; and Jason TC TZEN wrote the manuscript.